This Etsy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Avi Kapoor 3 months ago
Trading IdeasPre-Market OutlookNewsAnalyst RatingsDowngrades
Wall Street analysts change ratings for Pentair, Intellia Therapeutics, Etsy, Nutrien, and Ionis Pharmaceuticals. See what other analysts say.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Stifel analyst Nathan Jones downgraded Pentair PLC (NYSE:PNR) from Buy to Hold and cut the price target from $103 to $65. Pentair shares closed at $64.33 on Wednesday. See how other analysts view this stock.
- Wolfe Research analyst Andy Chen downgraded Intellia Therapeutics Inc (NASDAQ:NTLA) from Peer Perform to Underperform and announced a $9 price target. Intellia Therapeutics shares closed at $13.04 on Wednesday. See how other analysts view this stock.
- BTIG analyst Marvin Fong downgraded Etsy Inc (NYSE:ETSY) from Buy to Neutral. Etsy shares closed at $85.74 on Wednesday. See how other analysts view this stock.
- Jefferies analyst Laurence Alexander downgraded Nutrien Ltd (NYSE:NTR) from Buy to Hold and slashed the price target from $96 to $63. Nutrien shares closed at $68.33 on Tuesday. See how other analysts view this stock.
- Wolfe Research analyst Andy Chen downgraded Ionis Pharmaceuticals Inc (NASDAQ:IONS) from Outperform to Peer Perform. Ionis Pharmaceuticals shares closed at $54.73 on Wednesday. See how other analysts view this stock.
Considering buying ETSY stock? Here’s what analysts think:

Photo via Shutterstock